|Application:||Gene expression microarray analysis|
|Number of samples:||8|
|Release date:||May 5 2015|
|Last update date:||Oct 22 2018|
|Diseases:||Urinary Bladder Neoplasms, Cardiovascular Diseases, Arsenic Poisoning|
|Dataset link||Gene expression responses to chronic low dose arsenite exposure|
A total of eight (8) samples with two biological replicates under four separate conditions: wild-type treated with deionized H2O for 36 days (NT); chronic low-dose arsenic exposure of 1 uM of sodium arsenite (iAs-T) for 36 days; chronic arsenic exposure of 1 uM of sodium arsenite for 26 days followed by removal of sodium arsenite for 10 days, measured at day 36 (iAs-Rev); and chronic arsenic exposure of 1 uM of sodium arsenite for 26 days, followed by removal of sodium arsenite exposure for 10 days, followed by 1 uM of chronic sodium arsenite exposure for 10 days (measured at day 46) (iAs-Rev-T).
Eric Christian Rouchka